Dr. Christopher E. Nelson, President & CEO of KEMIN is chosen Hind Poultry's "PERSON WITH A VISION"

Dr. Christopher E. Nelson  President & CEO of KEMIN through his visionary ability and in depth knowledge of corporate world in Animal Heath Sector guided the KEMIN under his leadership to grow 10 times in size. The KEMIN now employs more than 2,500 people worldwide. Kemin touches more than 3.8 billion people across the globe every day with products for specific health and nutrition solutions.

In 1980, Dr. Nelson began his career with Kemin as director of research and development. During his tenure,  Dr. Christopher E. Nelson and his team pioneered the process of isolating and purifying the antioxidant molecule lutein for human consumption in supplements and fortified foods. Now, over 60 million people consume lutein daily through supplements and fortified foods. Among the many commercial and scientific advancements at Kemin, this distinguished breakthrough launched the company into new markets.

Dr. Nelson has been described as an industry pioneer, holding 15 patents and authoring numerous peer-reviewed, published research studies. He received his bachelor’s degree at Northwestern University and his Ph.D. in biochemistry and biophysics from Washington State University. He continues to have a passion for science education and is served as the Board Chair of the Science Center of Iowa. In his first term, he helped lead a successful development effort for construction of the $62 million Science Center.  Nelson is also the owner of MedPharm Iowa, the only licensed medical cannabis manufacturer in Iowa.

Dr. Nelson was recognized as one of the top 100 CEO Leaders in STEM (Science, Technology, Engineering, and Math) by STEM connector at the 2013 U.S. News & World Report’s STEM Solutions Summit. He had also been awarded the Life Time Achievement Award by Indian Poultry Journalists' Association in Hyderabad- India. 

Hind Poultry is proud of choosing Christopher E. Nelson as its first "Person with the vision" of its new series.

Post Date: 29 Jan 2022